SYNTHESIS AND SCREENING OF QUINAZOLINE ANALOGUES AS CYTOTOXIC AGENTS
Abstract
Synthesis of novel quinazoline derivatives was performed from reaction of N-benzoyl substituted piperazine-1-carbothioamide with 4-(2-chlormethyl) quinazoline-4-yloxy phenyl benzamide derivatives and screened for their in vitro cytotoxic activity by MTT assay. The cell lines used were MCF 7 (Breast cancer cell), HCT 15 (Colon cancer cell line), and VERO (Normal epidermal kidney cell). Result of screening on cell line showed moderate to good cytotoxic activity for all the compounds. Compound GNU 02 (IC50 = 7.94 µM, MCF), GNU 12 (IC50 = 8.43 µM, HCT) and GNU 25 (IC50 = 9.41 µM, HCT) was found to be most active compared to standard gefitinib (IC50 = 1.51 µM HCT, IC50 =22.37 µM MCF). Structure activity relationship of synthesized analogs suggested that the attachment of electron withdrawing groups like Nitro, Chloro gave better cytotoxic activity then unsubstituted phenyl and electron donating groups. Activity by substituted piperazine at 2nd position of thiazole linked with quinazoline scaffold gave better activity in the order of H > CH3 > C6H5. Our findings may impart new direction to medicinal chemists and biochemists for further investigations of quinazoline-thiazole containing cytotoxic agents.
Keywords:
Quinazoline, Thiazole, Cytotoxic, Piperazine, MTT assayDOI
https://doi.org/10.25004/IJPSDR.2016.080205References
2. Ashok K, Chatrasal SR. Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. Eur J Med Chem. 2009; 44:83–90.
3. Shuren Z, Joe W, Gudise C, Erika S, Xianjun L, Yongshen Z. Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents. Eur J Med Chem. 2010; 45:3864–3869.
4. Rajiv D, Anil K. Synthesis and biological activity of peptide derivatives of Iodoquinazolinones. Molecules. 2008; 13:958–976.
5. Buyuktimkin S, Ekinici AC. Pharmacological studies on quarternized-4-(3H) quinazolinones. J Pharm Sci. 1992; 81:1092–1094.
6. Fawzia MR, Amry E. The antihyperlipidemic activities of 4-(3H)-quinazolinone and two halogenated derivatives in rats. Lipid Health Dis. 2005; 4:22–24.
7. Kunes J, Bazant J, Pour M, Waisser K, Slosa´rek M, Janota J. Quinazoline derivatives with antitubercular activity. Farmaco. 2000; 55: 725–729.
8. Wasfy AAF. Synthesis and antimicrobial evaluation of some 2, 2-disubstituted-3, 3-biquinazolin-4-(3H)-ones. Indian J Chem B. 2003; 42B: 3102–3107.
9. Ashok K, Chatrasal SR. Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. Eur J Med Chem. 2009; 44 : 83–90.
10. Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P. Dijkstra, Ion Niculescu-Duvaz, Alfonso Zambon, Delphine Me´nard. Pyridoimidazolones as Novel Potent Inhibitors of v-Raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF). J. Med. Chem. 2009; 52: 2255–2264.
11. Hui H, Jian FG, Ling HC, Duo ZW, Zhin BZ. Synthesis of novel thioglycoside derivatives containing quinazolinone. J Chinese Chem Soc. 2009; 56:419–424.
12. Rajan G, Hardik T, Tony G, Williams J, Rogers D, Kamala V, Vasudevan S. Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-rB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents. Bio org Med Chem. 2010; 18:2796–2808.
13. Min Sun, Xiaoqing Wu, Junqing Chen, Jin Cai, Meng Cao, Min Ji. Design, synthesis and in vitro antitumor evaluation of novel diaryl ureas derivatives. European Journal of Medicinal Chemistry; 2010; 45: 2299-2306.
14. Robert J. Lancashire. Qualitative Analysis of organic compounds at http://www.chem.uwimona.edu.jm/lab_manuals/c10expt25.html.
15. Rajan G, Hardik T, Tony G, Bing C, Sam N, Kamala V, Vasudevan S. Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kβ, AP-1 mediated transcription and eIF-4E mediated translation activation: inhibitors of multi-pathways involve in cancer. European Journal of Medicinal Chemistry; 2010; 45: 3558-3563.
16. Sharma R. Synthesis and screening of 2-(2-(4-substituted piperazine-1-yl)-5-phenylthiazol-4-yl)-3-aryl quinazolinone derivatives as anticancer agents. Medicinal Chemistry Research; 2012; 21: 3327-3340.
17. Prakash S, Poonam S, Sarav AD, Maulik PS. In vitro cytotoxic evaluation of novel N-substituted bis-benzimidazole derivatives for anti-lung and anti-breast cancer activity. Ann Biological Research; 2011; 2: 51-59.
18. Rathi SG, Suthar M, Patel P, Bhaskar VH, Rajgor NB. Journal of young pharmacy; 1; 239-243.
Published
Abstract Display: 363 
PDF Downloads: 491 
